Caffeine for Prevention of Alzheimer’s Disease: Is the A<sub>2A</sub> Adenosine Receptor Its Target?

Caffeine for Prevention of Alzheimer’s Disease: Is the A<sub>2A</sub> Adenosine Receptor Its Target?

Alzheimer’s disease (AD) is the most prevalent kind of dementia with roughly 135 million cases expected in the world by 2050. Unfortunately, current medications for the treatment of AD can only relieve symptoms but they do not act as disease-modifying agents that can stop the course of AD. Caffeine...

Full description

Bibliographic Details
Main Authors: Stefania Merighi, Alessia Travagli, Manuela Nigro, Silvia Pasquini, Martina Cappello, Chiara Contri, Katia Varani, Fabrizio Vincenzi, Pier Andrea Borea, Stefania Gessi
Format: Article
Language:English
Published: MDPI AG 2023-06-01
Series:Biomolecules
Subjects:
A<sub>2A</sub> adenosine receptor
Alzheimer’s disease
amyloid beta
caffeine
neuroinflammation
therapeutic target
Online Access:https://www.mdpi.com/2218-273X/13/6/967

Internet

https://www.mdpi.com/2218-273X/13/6/967

Similar Items